Previous study identified that high protein expression of LCK is strongly correlated with favorable outcomes of CM patients, and tumors from the immune transcriptomic subgroup that correlate with pathological lymphocytic infiltration also express elevated levels of LCK protein 27. This evidence concerns the gene LCK and cutaneous mastocytosis.